Shares of Medtronic PLC MDT advanced 1.02% to $83.16 Wednesday, on what proved to be an all-around positive trading session ...

Shares of Medtronic PLC MDT slid 1.65% to $83.45 Monday, on what proved to be an all-around poor trading session for the ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025.

The medtech giant launched Medtronic Spark: a 10-year initiative designed to attract 1 million low-income students to careers in health tech.

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful ...

A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has ...

Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.

Medtronic (NYSE: MDT) announced positive primary and secondary outcomes for its VenaSeal spectrum venous leg ulcer (VLU) ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...